Edition:
India

LifeVantage Corp (LFVN.OQ)

LFVN.OQ on NASDAQ Stock Exchange Capital Market

4.54USD
19 Jan 2018
Change (% chg)

$0.11 (+2.48%)
Prev Close
$4.43
Open
$4.42
Day's High
$4.56
Day's Low
$4.42
Volume
7,335
Avg. Vol
11,882
52-wk High
$7.55
52-wk Low
$2.86

Chart for

About

LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy... (more)
No analyst recommendations are available for .

Overall

Beta: 0.55
Market Cap(Mil.): $66.87
Shares Outstanding(Mil.): 14.23
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 22.59 16.58
EPS (TTM): -- -- --
ROI: -- 12.23 10.60
ROE: -- 15.61 14.19

BRIEF-Lifevantage Says ‍Providing Notice Of Plaintiffs' Proposed Voluntary Dismissal Of Shareholder Derivative Actions

* LIFEVANTAGE SAYS ‍PROVIDING NOTICE OF PLAINTIFFS' PROPOSED VOLUNTARY DISMISSAL OF SHAREHOLDER DERIVATIVE ACTIONS Source text: (http://bit.ly/2D7WFIx) Further company coverage:

08 Jan 2018

BRIEF-Lifevantage reports $5 mln share repurchase program

* LIFEVANTAGE CORP - ‍EXPECTS TO FUND REPURCHASE PROGRAM THROUGH CASH ON HAND AND FUTURE CASH FLOW FROM OPERATIONS​ Source text for Eikon: Further company coverage:

27 Nov 2017

BRIEF-LifeVantage announces financial results for the first quarter

* LifeVantage announces financial results for the first quarter of fiscal 2018

09 Nov 2017

BRIEF-Lifevantage appoints Kevin Mcmurray as general counsel

* Lifevantage appoints Kevin Mcmurray as general counsel Source text for Eikon: Further company coverage:

02 Oct 2017

BRIEF-Lifevantage Q4 earnings per share $0.01

* Lifevantage announces financial results for the fourth fiscal quarter and full fiscal year 2017

08 Sep 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $147.36 +0.44
AstraZeneca plc (AZN.L) 5,043.00 +62.50
Prestige Brands Holdings, Inc. (PBH.N) $45.58 +0.47
Pfizer Inc. (PFE.N) $36.94 -0.05
Novartis AG (NOVN.S) CHF83.38 +0.48
Merck & Co., Inc. (MRK.N) $61.28 +0.15
Roche Holding Ltd. (ROG.S) CHF234.50 +1.30
Roche Holding Ltd. (RO.S) CHF237.80 +1.00
Abbott Laboratories (ABT.N) $59.31 +0.24

Earnings vs. Estimates